SCHEMBL9100211

SCHEMBL9100211

CCN(CC)c1ccc2cc(-c3ccc(NC)cc3)c(=O)oc2c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 3/20 0.71
MAPT P10636 13/20 0.57
MEN1 O00255 9/20 0.57
KMT2A Q03164 9/20 0.57
KDM4E B2RXH2 7/20 0.57
ALDH1A1 P00352 7/20 0.57
LMNA P02545 5/20 0.57
HTT P42858 5/20 0.57
SMN1; SMN2 Q16637 5/20 0.57
NPC1 O15118 4/20 0.57
USP2 O75604 4/20 0.57
RAB9A P51151 3/20 0.57
HPGD P15428 4/20 0.56
NR1H4 Q96RI1 1/20 0.55
NPSR1 Q6W5P4 3/20 0.55
ATM Q13315 5/20 0.54
MAOB P27338 3/20 0.54
HSD17B10 Q99714 2/20 0.54
CYP1A2 P05177 1/20 0.54
CYP2C19 P33261 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13869250 0.91 CYP19A1 (0.86) CYP19A1MAPTMEN1KMT2AKDM4E
SCHEMBL13869303 0.90 CYP19A1 (0.83) CYP19A1MAPTMEN1KMT2AKDM4E
SCHEMBL28136852 0.89 CYP19A1 (0.70) CYP19A1MAPTMEN1KMT2AKDM4E
SCHEMBL13870251 0.89 CYP19A1 (0.81) CYP19A1MAPTMEN1KMT2AKDM4E
SCHEMBL13870275 0.89 CYP19A1 (0.81) CYP19A1MAPTMEN1KMT2AKDM4E
SCHEMBL13869498 0.87 CYP19A1 (0.79) CYP19A1MAPTMEN1KMT2AKDM4E
SCHEMBL11207290 0.86 CYP19A1 (0.77) CYP19A1MAPTMEN1KMT2AKDM4E
SCHEMBL13869506 0.86 CYP19A1 (0.86) CYP19A1MAPTMEN1KMT2AKDM4E
SCHEMBL5935133 0.85 CYP19A1 (0.75) CYP19A1MAPTMEN1KMT2AKDM4E
SCHEMBL29767702 0.85 CYP19A1 (0.75) CYP19A1MAPTMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0428939-B1 Cumarin derivatives, process for their preparation, their use and thiazolylacetic acid derivatives as intermediate BAYER AG (DE) 1996-01-17 EP disclosed
US-5300656-A Immunoassay BAYER AKTIENGESELLSCHAFT (DE) 1994-04-05 US disclosed
EP-0428939-A2 Cumarin derivatives, process for their preparation, their use and thiazolylacetic acid derivatives as intermediate BAYER AG (DE) 1991-05-29 EP disclosed